References
- Wald N, Frost C, Cuckle H. Breast cancer screening: The current position. Br Med J 1991; 302: 845–6
- Wilkinson G S, Edgerton F, Wallace H J. Delay, stage of disease and survival from breast cancer. J Chronic Dis 1979; 32: 365–73
- Elwood J M, Moorehead W P. Delay in diagnosis and long-term survival in breast cancer. BMJ 1980; 280: 1291–4
- Feldman J G, Saunders M, Carter A C. The effects of patients delay and symptoms other than a lump on survival in breast cancer. Cancer 1983; 51: 1226–9
- Robinson E, Mohilever J, Zidan J. Delay in diagnosis of cancer. Cancer 1984; 54: 1454–60
- Tablar L, Gad A. Screening for breast cancer—the Swedish trial. Radiology 1981; 138: 219–22
- Karjalainen S, Aareleid T, Hakulinen T. Survival of female breast cancer patients in Finland and Estonia: Stage at diagnosis. Important determinant of the difference between countries. Soc Sci Med 1989; 28: 233–8
- Berkson J. Prognosis of malignant tumors of the breast: A review of recent experience of the Mayo Clinic. Acta Union Internationalis Contra Cancrum 1962; 18: 1003–8
- Moore F D. Breast self-examination. N Engl J Med 1978; 299: 304–5
- Lewis D, Reinhoff W F. A study of the results of operations for the cure of cancer of the breast. Ann Surg 1931; 95: 336–400
- Dennis C R, Gardner B, Lim B. Analysis of survival and recurrence vs. patient and doctor delay of breast cancer. Cancer 1975; 35: 714–20
- Fisher E R, Redmond C, Fisher B. A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer. Cancer 1977; 40: 3160–7
- Neave L M, Mason B H, Kay R G. Does delay in diagnosis of breast cancer affect delay?. Breast Cancer Res Treat 1990; 15: 103–8
- Bloom H JG, Richardson W W. Histological grading and prognosis in breast cancer. Br J Cancer 1957; 11: 359–77
- Andersen K W, Mouridsen H T. DBCG. A description of the register of the nation-wide programme for primary breast cancer. Acta Oncol 1988; 27: 627–47
- Foulds L. Neoplastic development. New York Acad Press. 1975; 675–93
- Tubiana M, Koscielny S. Natural history of human breast cancer: Resent data and clinical implications. Breast Cancer Res Treat 1991; 18: 125–40
- Greshon-Cohen J, Berger S M, Klickstein H S. Roentgraphy of breast cancer of ‘biologic predeterminism’. Cancer 1963; 16: 961–4
- Carter C L, Allen C, Henson D E. Relation of tumor size, lymph node status, and survival in 24 740 breast cancer cases. Cancer 1989; 63: 181–7
- Adam S A, Homer J K, Vessey M P. Delay in treatment for breast cancer. Community Med 1980; 2: 195–201
- Nichols S, Waters W E, Fraser J D. Delay in the presentation of breast symptoms for consultant investigation. Community Med 1981; 3: 217–25
- MacArthur C C, Smith A. Delay in breast cancer and the nature of presenting symptoms. Lancet 1981; 1: 601–3
- Adami H-O, Malker B, Holmberg L. The relation between survival and age at diagnosis in breast cancer. N Engl J Med 1986; 315: 559–63
- McGuire L, Clark G M. Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 1992; 326: 1756–61
- Galea M H, Blarney R W, Elston C E. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992; 22: 207–19
- Moskowitz B. Breast cancer: Age-specific growth rates and screening strategies. Radiology 1986; 1: 3741
- Tabar L, Faberberg G, Day N E, Holmberg L. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-country breast cancer screening trial. Br J Cancer 1987; 55: 547–51